Bibliografia Yamanaka, C., Lebrethon, M. C., Vandersmissen, E., Gerard, A., Purnelle, G., Lemaitre, M., Wilk, S. and Bourguignon, J. P., 1999. Early prepubertal ontogeny of pulsatile gonadotropin-releasing hormone (GnRH) secretion: I. Inhibitory autofeedback control through prolyl endopeptidase degradation of GnRH. Endocrinology. 140, 4609-4615. Yanaihara, N., Sakagami, M., Sato, H., Yammamoto, K. and Hashimoto, T., 1977. Immunological aspects of secretin, substance P, and VIP. Gastroenterology. 72, 803-810. Ye, P., Xing, Y., Dai, Z. and D'Ercole, A. J., 1996. In vivo actions of insulin-like growth factor-I (IGF-I) on cerebellum development in transgenic mice: evidence that IGF-I increases proliferation of granule cell progenitors. Brain Res Dev Brain Res. 95, 44-54. Yoshida, K., Inaba, K., Ohtake, H. and Morisawa, M., 1999. Purification and characterization of prolyl endopeptidase from the Pacific herring, Clupea pallasi, and its role in the activation of sperm motility. Dev Growth Differ. 41, 217-225. Yoshimoto, T., Kado, K., Matsubara, F., Koriyama, N., Kaneto, H. and Tsura, D., 1987. Specific inhibitors for prolyl endopeptidase and their anti-amnesic effect. J Pharmacobiodyn. 10, 730-735. Yoshimoto, T., Ogita, K., Walter, R., Koida, M. and Tsuru, D., 1979. Post-proline cleaving enzyme. Synthesis of a new fluorogenic substrate and distribution of the endopeptidase in rat tissues and body fluids of man. Biochim Biophys Acta. 569, 184-192. Yoshimoto, T., Shimoda, T., Kitazono, A., Kabashima, T., Ito, K. and Tsuru, D., 1993. Pyroglutamyl peptidase gene from Bacillus amyloliquefaciens: cloning, sequencing, expression, and crystallization of the expressed enzyme. J Biochem (Tokyo). 113, 67-73. Yoshimoto, T., Tabira, J., Kabashima, T., Inoue, S. and Ito, K., 1995. Protease II from Moraxella lacunata: cloning, sequencing, and expression of the enzyme gene, and crystallization of the expressed enzyme. J Biochem (Tokyo). 117, 654-660. Zabavnik, J., Arbuthnott, G. and Eidne, K. A., 1993. Distribution of thyrotrophinreleasing hormone receptor messenger RNA in rat pituitary and brain. Neuroscience. 53, 877-887. Zagon, I. S., Gibo, D. M. and McLaughlin, P. J., 1991. Z<strong>eta</strong> (z<strong>eta</strong>), a growth-related opioid receptor in developing rat cerebellum: identification and characterization. Brain Res. 551, 28-35. Zagon, I. S. and McLaughlin, P., 1988. Endogenous opioids and the growth regulation of a neural tumor. Life Sci. 43, 1313-1318. Zagon, I. S. and McLaughlin, P. J., 1984. Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth. Life Sci. 35, 2057-2064. Zagon, I. S. and McLaughlin, P. J., 1989. Endogenous opioid systems regulate growth of neural tumor cells in culture. Brain Res. 490, 14-25. Zagon, I. S., Sassani, J. W. and McLaughlin, P. J., 1995. Opioid growth factor modulates corneal epithelial outgrowth in tissue culture. Am J Physiol. 268, R942-950. Bibliografia 249
Bibliografia Zagon, I. S., Verderame, M. F., Allen, S. S. and McLaughlin, P. J., 2000. Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans. Brain Res. 856, 75-83. Zagon, I. S., Wu, Y. and McLaughlin, P. J., 1994. Opioid growth factor inhibits DNA synthesis in mouse tongue epithelium in a circadian rhythm-dependent manner. Am J Physiol. 267, R645-652. Zagon, I. S., Wu, Y. and McLaughlin, P. J., 1999. Opioid growth factor and organ development in rat and human embryos. Brain Res. 839, 313-322. Zambrzycka, A., Alberghina, M. and Strosznajder, J. B., 2002. Effects of aging and amyloid-b<strong>eta</strong> peptides on choline acetyltransferase activity in rat brain. Neurochem Res. 27, 277-281. Zheng, D., Chen, H. S. and Hu, D. Y., 1992. Cardiovascular mechanisms of thyrotropin-releasing hormone against experimental hemorrhagic shock. Circ Shock. 36, 169-173. Zoli, M., Magalotti, D., Bianchi, G., Gueli, C., Orlandini, C., Grimaldi, M. and Marchesini, G., 1999. Total and functional hepatic blood flow decrease in parallel with ageing. Age Ageing. 28, 29-33. Zulaika, J., 1986. Actividad de amino<strong>peptidasa</strong>s en el desarrollo cerebral postnatal de la rata. In: Lizentziatura tesina; Zientzi<strong>eta</strong>ko Fakultatea). UPV/EHU, Leioa. Zupan, V., Hill, J. M., Brenneman, D. E., Gozes, I., Fridkin, M., Robberecht, P., Evrard, P. and Gressens, P., 1998. Involvement of pituitary adenylate cyclaseactivating polypeptide II vasoactive intestinal peptide 2 receptor in mouse neocortical astrocytogenesis. J Neurochem. 70, 2165-2173. Internetetik lortutako aipamenak: http:.//ifcsun1.fisiol.unam.mx/Brain/devel.htm http://www.neurosci.pharm.utoledo.edu/MBC4420/anatomy.htm 250 Bibliografia
- Page 1 and 2:
Jakintza-arloa: Medikuntza Prolil e
- Page 3 and 4:
UNIVERSIDAD DEL PAIS VASCO Eman ta
- Page 5 and 6:
Doktore-tesia Naiara Agirregoitia M
- Page 7 and 8:
Esker onak Lan hau hasi nuenetik mo
- Page 9:
David Artola Blancoren Oroimenez Es
- Page 12 and 13:
Aurkibidea SARRERA 1.NEUROPEPTIDOAK
- Page 14 and 15:
Aurkibidea 7.4. BIRIKAK 65 7.5. GIL
- Page 16:
Aurkibidea 2.4.PIROGLUTAMIL PEPTIDA
- Page 19 and 20:
Sarrera 2 Sarrera
- Page 21 and 22:
Neuropeptidoak dira: 4 Hurrengo tau
- Page 23 and 24:
Neuropeptidoak 6 1.2.4. Askapena Ne
- Page 26 and 27:
Tirotropinaren Hormona Askatzailea
- Page 28 and 29:
Tirotropinaren Hormona Askatzailea
- Page 30 and 31:
Tirotropinaren Hormona Askatzailea
- Page 32 and 33:
Tirotropinaren Hormona Askatzailea
- Page 34:
Tirotropinaren Hormona Askatzailea
- Page 37 and 38:
Prolil endopeptidasa burututako leh
- Page 39 and 40:
Prolil endopeptidasa 22 3.3. PROLIL
- Page 41 and 42:
Prolil endopeptidasa 24 3.5. GARRAN
- Page 43 and 44:
Piroglutamil peptidasa I Mutagenesi
- Page 45 and 46:
Piroglutamil peptidasa I Katuaren g
- Page 48 and 49:
5. GARUN GARAPENA 5.1. SARRERA 5.1.
- Page 50 and 51:
Garun garapena Rhombentzefaloaren k
- Page 52 and 53:
Garun garapena mekanismoa hurrengoe
- Page 54 and 55:
Garun garapena Oinarrizko morfologi
- Page 56 and 57:
Garun garapena egunetan, baina 40.
- Page 58 and 59:
Garun garapena badaude, eta entzima
- Page 60 and 61:
Garun garapena neuronen genesia (Fr
- Page 62 and 63:
Garun garapena hipotiroideoaren adi
- Page 64 and 65:
Garun garapena azpiko zati bat. Bi
- Page 66 and 67:
Garun garapena lank., 1984; Gayo et
- Page 68 and 69:
Organo periferikoen garapena 6.ORGA
- Page 70 and 71:
Organo periferikoen garapena Peptid
- Page 72 and 73:
Organo periferikoen garapena eta la
- Page 74 and 75:
Organo periferikoen garapena Birike
- Page 76:
Organo periferikoen garapena ondore
- Page 79 and 80:
Zahartzapena Entzefalinak eta TRH-a
- Page 81 and 82:
Zahartzapena Bradikininaren hartzai
- Page 83 and 84:
Zahartzapena igoerarekin bat dator.
- Page 86 and 87:
HELBURUA
- Page 88 and 89:
HELBURUA Helburua Organismoaren haz
- Page 90 and 91:
Helburua Peptidasa solugarrien egin
- Page 92 and 93:
MATERIALAK ETA METODOAK
- Page 94 and 95:
MATERIALAK ETA METODOAK Materialak
- Page 96 and 97:
3. PRODUKTU KIMIKOAK o Azetato sodi
- Page 98 and 99:
Materialak 4.2.ENTSEIU ENTZIMATIKOE
- Page 100 and 101:
B. METODOAK 1. ANIMALIEN PERFUSIO E
- Page 102 and 103:
1. IRUDIA: Animaliaren perfusioa. M
- Page 104 and 105:
3. IRUDIA: Garunaren lehenengo ebak
- Page 106 and 107:
2. LAGINEN PRESTAKUNTZA Metodoak Au
- Page 108 and 109:
Metodoak 3.AKTIBITATE ENTZIMATIKOAR
- Page 110 and 111:
Teknika Metodoak Substratu soluzioa
- Page 112 and 113:
Metodoak Materialak eta Metodoak 95
- Page 114 and 115:
EMAITZAK Prolil endopeptidasa solug
- Page 116:
UP/mg proteina 3000 2000 1000 0 Pro
- Page 119 and 120:
Mintzari loturiko prolil endopeptid
- Page 122 and 123:
1.2. PIROGLUTAMIL PEPTIDASA I 1.2.1
- Page 124:
UP/mg proteina 5000 4000 3000 2000
- Page 127 and 128:
Mintzari loturiko piroglutamil pept
- Page 129 and 130:
Prolil endopeptidasa garapenean 112
- Page 131 and 132:
Prolil endopeptidasa garapenean ham
- Page 133 and 134:
Prolil endopeptidasa garapenean PRO
- Page 135 and 136:
Prolil endopeptidasa garapenean Kor
- Page 137 and 138:
Prolil endopeptidasa solugarria gar
- Page 139 and 140:
Prolil endopeptidasa solugarria gar
- Page 141 and 142:
Prolil endopeptidasa solugarria gar
- Page 143 and 144:
Mintzari loturiko prolil endopeptid
- Page 146 and 147:
Mintzari loturiko prolil endopeptid
- Page 148 and 149:
Mintzari loturiko prolil endopeptid
- Page 150 and 151:
Mintzari loturiko prolil endopeptid
- Page 152 and 153:
UP/mg proteina 3000 2000 1000 0 Min
- Page 154 and 155:
UP/mg proteina 500 400 300 200 100
- Page 156 and 157:
UP/mg proteina 300 200 100 0 Mintza
- Page 158 and 159:
Piroglutamil peptidasa I solugarria
- Page 160 and 161:
Piroglutamil peptidasa I solugarria
- Page 162 and 163:
Piroglutamil peptidasa I solugarria
- Page 164 and 165:
Piroglutamil peptidasa I solugarria
- Page 166 and 167:
Piroglutamil peptidasa I solugarria
- Page 168 and 169:
Piroglutamil peptidasa I solugarria
- Page 170 and 171:
Mintzari loturiko piroglutamil pept
- Page 172 and 173:
Mintzari loturiko piroglutamil pept
- Page 174 and 175:
UP/mg proteina 600 400 200 0 Mintza
- Page 176 and 177:
UP/mg proteina 400 300 200 100 0 Mi
- Page 178 and 179:
UP/mg proteina 400 300 200 100 0 Mi
- Page 180 and 181:
UP/mg proteina 200 150 100 50 0 Min
- Page 182 and 183:
UP/mg proteina 150 100 50 0 Mintzar
- Page 184 and 185:
Prolil endopeptidasa zahartzapenean
- Page 186 and 187:
Prolil endopeptidasa zahartzapenean
- Page 188 and 189:
Prolil endopeptidasa zahartzapenean
- Page 190 and 191:
Prolil endopeptidasa zahartzapenean
- Page 192 and 193:
Prolil endopeptidasa zahartzapenean
- Page 194 and 195:
Piroglutamil peptidasa I solugarria
- Page 196 and 197:
UP/ mg proteina 400 300 200 100 0 P
- Page 198:
UP/ mg proteina 5000 4000 3000 2000
- Page 201 and 202:
Piroglutamil peptidasa I solugarria
- Page 203 and 204:
Piroglutamil peptidasa I solugarria
- Page 205 and 206:
EZTABAIDA
- Page 207 and 208:
EZTABAIDA 1. PROLIL ENDOPEPTIDASA P
- Page 209 and 210:
Prolil endopeptidasa Jaio berrian e
- Page 211 and 212: Prolil endopeptidasa peptido hauek
- Page 213: Prolil endopeptidasa 1.4. PROLIL EN
- Page 216 and 217: Piroglutamil peptidasa I Lehen aipa
- Page 218 and 219: Piroglutamil peptidasa I TRH-aren e
- Page 221 and 222: Emaitzen Analisi orokorra 3. EMAITZ
- Page 223 and 224: ONDORIOAK
- Page 225 and 226: ONDORIOAK Ondorioak 1. Prolil endop
- Page 228: BIBLIOGRAFIA
- Page 231 and 232: Bibliografia Aoyagi, T., Hatsu, M.,
- Page 233 and 234: Bibliografia Berl, S. and Clarke, D
- Page 235 and 236: Bibliografia Carr, F. E., Need, L.
- Page 237 and 238: Bibliografia de Gandarias, J. M., C
- Page 239 and 240: Bibliografia el-Dahr, S. S., 1997.
- Page 241 and 242: Bibliografia Gil, J., 1997. Ontogen
- Page 243 and 244: Bibliografia importance of cardiac
- Page 245 and 246: Bibliografia converting enzyme inhi
- Page 247 and 248: Bibliografia Lee, H. J., Sagawa, K.
- Page 249 and 250: Bibliografia Manaker, S., Eichen, A
- Page 251 and 252: Bibliografia hormone (TRH) in the p
- Page 253 and 254: Bibliografia Otto, C., Zuschratter,
- Page 255 and 256: Bibliografia Re, R. N., 2003a. Impl
- Page 257 and 258: Bibliografia Sidman, R. L., 1961. H
- Page 259 and 260: Bibliografia ten Have-Opbroek, A. A
- Page 261: Bibliografia Weil-Malherbe, H., 197